En este Endotips pasaremos a revisar las ultimas guías publicadas en JAMA, la importancia de las hepatoquinas y la relación con diabetes y enfermedad cardiovascular.
- Nonalcoholic fatty liver disease: a systematic review. Rinella ME. JAMA. 2015 Jun 9;313(22):2263-73. PDF
- Hepatokines: unlocking the multi-organ network in metabolic diseases.Iroz A1 Couty JP, Postic C. Diabetologia. 2015 Aug;58(8):1699-703. PDF
- Hepatokines as a Link between Obesity and Cardiovascular Diseases. Yoo HJ, Choi KM. Diabetes Metab J. 2015 Feb;39(1):10-5. PDF
- Nonalcoholic fatty liver disease and statins. Tziomalos K, Athyros VG, Paschos P, Karagiannis A Metabolism. 2015 Oct;64(10):1215-23. PDF
- Fatty liver disease in diabetes mellitus. Bhatt HB, Smith RJ. Hepatobiliary Surg Nutr. 2015 Apr;4(2):101-8. PDF
